We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.
LUTATHERA Novartis Pharmaceuticals Australia Pty Ltd
Product name
LUTATHERA
Accepted date
Sep-2024
Active ingredients
lutetium (177Lu) oxodotreotide
Proposed indication
Treatment of somatostatin receptor-positive
gastroenteropancreatic neuroendocrine tumours in adults.
gastroenteropancreatic neuroendocrine tumours in adults.
Application type
A (new medicine)
Publication date
Sep-2024